Neratinib Completed Phase 1 / 2 Trials for Cancer, Breast / Advanced Malignant Solid Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT01128842A Study Of Neratinib (HKI-272) And Capecitabine In Japanese With Solid Tumor
NCT00768469Study Evaluating Safety And Tolerability, Solid Tumor
NCT00958724Study Evaluating Neratinib In Combination With Vinorelbine In Subjects With Advanced Or Metastatic Solid Tumors
NCT01423123Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer
NCT00708903Study to Examine the Effect of HKI-272 on Rhythms of the Heart (Cardiac Repolarization)